PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE

• Raffaella Colombatti,
• Julie Kanter,
• Eric Wu,
• Leila J. Clay,
• Andrew Campbell

Affiliations

Raffaella Colombatti

1 Azienda Ospedale-University of Padova, Department of Women’s and Child’s Health, Pediatric Hematology Oncology Unit, Padova, Italy

Julie Kanter

2 University of Alabama, Division of Hematology and Oncology, Birmingham, Alabama, United States

Eric Wu

3 Novo Nordisk Inc., Watertown, Massachusetts, United States

Leila J. Clay

3 Novo Nordisk Inc., Watertown, Massachusetts, United States

Andrew Campbell

4 Children’s National Hospital, Center for Cancer and Blood Disorders, Washington DC, United States